Warfarin: pharmacological profile and drug interactions with antidepressants

Einstein (Sao Paulo). 2012 Jan-Mar;10(1):110-5. doi: 10.1590/s1679-45082012000100024.

Abstract

Oral anticoagulants are among the drugs with the greatest number of drug interactions. The concomitant use of several medications is a common practice in patients with cardiovascular problems, who often also present with depression; therefore, the probability of an interaction occurring between warfarin and the antidepressants is high, and may result in increased or decreased anticoagulant activity. Since the possible interactions between these two classes of drugs have been poorly explored in literature, with a risk to the patients who use them, we reviewed the pharmacology of warfarin and its possible interactions with antidepressants. Of the antidepressants analyzed, those that showed relevant effects on the interaction with warfarin were, in decreasing order: paroxetine, venlafaxine, fluoxetine, and duloxetine.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / pharmacology*
  • Anticoagulants / therapeutic use
  • Antidepressive Agents / pharmacology*
  • Biotransformation / drug effects
  • Cyclohexanols / pharmacology
  • Cytochrome P-450 Enzyme System / metabolism
  • Drug Interactions
  • Duloxetine Hydrochloride
  • Fluoxetine / pharmacology
  • Hemorrhage / chemically induced
  • Humans
  • Paroxetine / pharmacology
  • Thiophenes / pharmacology
  • Thrombophilia / drug therapy
  • Venlafaxine Hydrochloride
  • Vitamin K / antagonists & inhibitors
  • Warfarin / adverse effects
  • Warfarin / pharmacokinetics
  • Warfarin / pharmacology*
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Antidepressive Agents
  • Cyclohexanols
  • Thiophenes
  • Fluoxetine
  • Vitamin K
  • Paroxetine
  • Warfarin
  • Venlafaxine Hydrochloride
  • Cytochrome P-450 Enzyme System
  • Duloxetine Hydrochloride